Product Information
MUCUS RLF DM MAX 400-20 MG/20 ML is a generic product labeled by Cardinal Health, priced at $0.0212 per ML under NDC 70000070701. Its NADAC has been published 74 times since May 7, 2025.
Strength
20; 400 mg/20mL; mg/20mL
Manufacturer
Cardinal HealthNDC
70000070701
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
9/24/2024
Pharmacological Classes
Price Statistics
The NADAC for MUCUS RLF DM MAX 400-20 MG/20 ML has been published 74 times since May 7, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0212 per ML |
|---|---|
| All-time high | $0.0217 (May 13, 2026) |
| All-time low | $0.0211 (Jul 22, 2026) |
| 52-week high | $0.0217 |
| 52-week low | $0.0211 |
| Median price | $0.0213 |
| Average price | $0.0213 |
| Largest weekly change | -1.2% (May 20, 2026) |
| Weeks tracked | 74 |
| Tracking since | May 7, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr, Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUCUS RLF DM MAX 400-20 MG/20 ML?
The current National Average Drug Acquisition Cost (NADAC) for MUCUS RLF DM MAX 400-20 MG/20 ML, manufactured by Cardinal Health, is $0.0212 per ML (NDC 70000070701), effective Sep 30, 2026.
How has the price of MUCUS RLF DM MAX 400-20 MG/20 ML changed over time?
Over the history we have for it, the NADAC for MUCUS RLF DM MAX 400-20 MG/20 ML has held within roughly two percent of its current level. It has been tracked across 74 weekly CMS publications since May 7, 2025.
What are the highest and lowest recorded NADAC prices for MUCUS RLF DM MAX 400-20 MG/20 ML?
Since May 7, 2025, the NADAC for MUCUS RLF DM MAX 400-20 MG/20 ML has ranged from a low of $0.0211 (Jul 22, 2026) to a high of $0.0217 (May 13, 2026), with a median of $0.0213 per ML.
Are there cheaper alternatives to MUCUS RLF DM MAX 400-20 MG/20 ML?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TUSSIN DM 400-20 MG/20 ML LIQ, is $0.0178 per ML — about 16% below MUCUS RLF DM MAX 400-20 MG/20 ML.
Who manufactures MUCUS RLF DM MAX 400-20 MG/20 ML?
MUCUS RLF DM MAX 400-20 MG/20 ML (NDC 70000070701) is labeled by Cardinal Health, and CMS classifies it as a generic product.